about
Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy.Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.Statin therapy in heart failure: for good, for bad, or indifferent?Incidence of atrial fibrillation is associated with age and gender in subjects practicing physical exercise: A meta-analysis and meta-regression analysis.Pre-hospital electrocardiogram triage with telemedicine near halves time to treatment in STEMI: A meta-analysis and meta-regression analysis of non-randomized studies.Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study.Drug treatment rates with beta-blockers and ACE-inhibitors/angiotensin receptor blockers and recurrences in takotsubo cardiomyopathy: A meta-regression analysis.Sildenafil improves clinical and functional status of an elderly postmenopausal female with 'out of proportion' PH associated with left heart disease.Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison.Scared for the scar: fearsome impact of acute cardiovascular disease on perceived kinesiophobia (fear of movement).Macitentan Use in a Neurofibromatosis Type 1 Patient With Pulmonary Hypertension and External Jugular Phlebectasia.ABCB1 SNP rs4148738 modulation of apixaban interindividual variability."PAFIYAMA" syndrome; further evidence on a novel clinical entity.Big atria, little P waves: unexpected mismatch between chamber volume and electrocardiogram signal in "false" atrial fibrillation.Troponin release after newborns ergot poisoning: heart, lung or circulation?Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?
P50
Q31089116-C694B44D-3812-43E2-B823-B8AC3571D2E1Q37653029-550522DA-C228-40B0-8ACD-EDF779DB1348Q38134850-A4620611-0670-4370-A8E9-BBC7552E16ECQ38166321-15307216-9CE6-48F7-B629-76E1C9870C63Q38905578-BC12F07D-B708-4F82-89F5-ACC63D4D9BCEQ39019958-B4BBDF6B-BACA-4D91-B0DA-EAE7826E2373Q39035257-147CB319-EF95-4C66-88F2-BB5A65D4C0A2Q39846126-4630C8A3-9CA0-4417-9EFD-36C8025DDCF1Q46551741-7B8E963B-13AF-4B47-AEAB-0F3531BB6E27Q47631869-0571AD84-0674-4AE6-8445-33CE653FF293Q48150513-C1CC6DAE-9734-4128-9925-653F4E24A130Q50068584-54E708FA-1954-4493-BBD3-1D02C233D1BAQ51630837-86DB9C46-0AB1-4CE3-A22F-7FD452206B6FQ52707640-682AB467-C013-4B17-ADB8-B70481A469AAQ53183911-2B0B91B6-F2DC-4DA0-AC14-4BBBC4D1322FQ54410667-A2CD3C20-05C5-4529-AAAD-E33AAD959601Q57484162-14A262AA-3BBB-4F94-AA65-A10080ABAC39
P50
description
researcher
@en
wetenschapper
@nl
name
Michele Correale
@en
Michele Correale
@nl
type
label
Michele Correale
@en
Michele Correale
@nl
prefLabel
Michele Correale
@en
Michele Correale
@nl
P31
P496
0000-0002-7863-253X